[1] YANAI A,UCHIYAMA K,ISHIBASHI Y.Uremic encephalopathy in patients undergoing assisted peritoneal dialysis:A case series and literature review[J].CEN Case Rep,2019,8(4):271-279. [2] LU W,REN C,HAN X,et al.The protective effect of different dialysis types on residual renal function in patients with maintenance hemodialysis:A systematic review and meta-analysis[J].Medicine,2018,97(37):e12325. [3] NAUTA L,VOORZAAT BM,ROTMANS J I,et al.Endovascular salvage of non-maturing autogenous arteriovenous fistulas by using angioplasty and competitive vein embolization[J].J Vasc Access,2020,21(5):615-622. [4] 王吉萍,陈海金,吴丽华,等.B超引导下经皮腔内血管成形术治疗血液透析患者自体动静脉内瘘狭窄的疗效研究[J].临床和实验医学杂志,2022,21(2):215-218. [5] 柴耸豪,梁献慧,王晓星.正念减压疗法对AVF术后老年维持性血液透析患者负面情绪及应对方式的影响[J].国际精神病学杂志,2022,49(1):145-148. [6] SUQIN L,MINGLI Z,SHITENG S,et al.Assessment of the hemodynamics of autogenous arteriovenous fistulas with 4D phase contrast-based flow quantification MRI in dialysis patients[J].J Magn Reson Imaging,2020,51(4):1272-1280. [7] 李琛,梅克文,任树荣.维持性血液透析患者自体动静脉内瘘自我管理与生活质量相关性分析[J].护理实践与研究,2020,17(8):1-4. [8] 黄玉萍,王道洋,周玉叶,等.蚌埠市维持性血液透析患者血管通路使用情况及影响因素分析[J].中国血液净化,2021,20(6):415-419. [9] 曹雯,宋斌,廖祖春,等.德阳地区1550例维持性血液透析患者长期血管通路横断面调查分析[J].中国血液净化,2020,19(2):116-119. [10] 李志玲,王新文.不同血管通路血液透析患者透析充分性评估及并发症发生率的比较[J].昆明医科大学学报,2020,41(3):116-120. [11] 梁颖,付群英.可能影响维持性血液透析患者动静脉内瘘功能不良因素分析及护理对策[J].贵州医药,2020,44(12):1979-1980. [12] ARHUIDESE I J,PUROHIT A,ELEMUO C,et al.Outcomes of autogenous fistulas and prosthetic grafts for hemodialysis access in diabetic and nondiabetic patients[J].J Vasc Surg,2020,72(6):2088-2096. [13] 韩霞,马文强,夏丽华.参芪通脉方防治糖尿病肾病患者自体动静脉内瘘早期失功的疗效及对纤溶系统功能、脂质代谢与转化生长因子-β1的影响[J].现代中西医结合杂志,2021,30(8):838-842. [14] 周敏,卢方平.高磷血症对自体动静脉内瘘功能不良/失功再次手术后通畅率的影响[J].中华医学杂志,2018,98(42):3406-3410. [15] 段丽娜. 高通量透析治疗对尿毒症血液透析患者中低分子蛋白的清除与血脂代谢的影响[J].国际医药卫生导报,2017,23(5):695-697. |